| childbearing and contraceptive-use plans among women at high risk for hiv infection--selected u.s. sites, 1989-1991. | from september 1990 through august 1991, 2655 (49%) of the 5457 women reported with acquired immunodeficiency syndrome (aids) in the united states had been injecting-drug users (idus), and 1136 (21%) had had sexual intercourse with men who were idus (1). during the same period, 413 (56%) of the 735 children (aged less than 13 years) reported with aids were born to mothers who were either idus (38%) or sex partners of idus (18%) (1). even though messages and services regarding prevention of human ... | 1992 | 1738361 |
| prevalence of hiv infection in childbearing women in the united states. surveillance using newborn blood samples. | a national, population-based survey was initiated in 1988 to measure the prevalence of human immunodeficiency virus (hiv) infection in women giving birth to infants in the united states. following standardized procedures, residual dried-blood specimens collected on filter paper for newborn metabolic screening were tested anonymously in state public health laboratories for maternal antibody to hiv. as of september 1990, annual survey data were available from 38 states and the district of columbia ... | 1991 | 2002571 |
| teenagers' knowledge of the acquired immunodeficiency syndrome and associated risk behaviors. | adolescents are now recognized as being at high risk for contracting the human immunodeficiency virus (hiv), the presumed cause of acquired immunodeficiency syndrome (aids). this article reports the findings of a survey that examined aids knowledge, risk behaviors, and informational sources for aids in a group of suburban new jersey high school students (n = 152). this group had knowledge of hiv and its transmission, but results indicated that students also participated in behaviors considered " ... | 1992 | 1507059 |
| cumulative aids incidence and altered mortality from mycobacterial disease: new jersey. | changes in mycobacterial disease mortality between 1980 and 1986 were examined among new jersey residents aged 25 to 44 using single cause of death data. the demographic group with the highest cumulative incidence of acquired immune deficiency syndrome (aids) (non-white residents of the four urban counties adjacent to new york city) sustained an increase of 10.1 deaths/100,000 men/yr and 3.1 deaths/100,000 women/yr. groups with lower cumulative incidence of aids sustained smaller increases in my ... | 1991 | 2008983 |
| expression and processing of human immunodeficiency virus type 1 gp160 using the vesicular stomatitis virus new jersey serotype vector system. | the indiana serotype of vesicular stomatitis virus (vsv(ind)), but not the new jersey serotype (vsv(nj)), has been widely used as a gene expression vector. in terms of prime-boost-based vaccine strategies, it would be desirable to use two different vsv serotypes to avoid immunity against the priming viral vector. here, we report that we have applied the vsv(nj) vector system for expression of the env gene of human immunodeficiency virus type 1 (hiv-1). the hiv-1 env gene was inserted into the vs ... | 2009 | 19264597 |
| cancer risk in people infected with human immunodeficiency virus in the united states. | data are limited regarding cancer risk in human immunodeficiency virus (hiv)-infected persons with modest immunosuppression, before the onset of acquired immunodeficiency syndrome (aids). for some cancers, risk may be affected by highly active antiretroviral therapy (haart) widely available since 1996. we linked hiv/aids and cancer registries in colorado, florida and new jersey. standardized incidence ratios (sirs) compared cancer risk in hiv-infected persons (initially aids-free) during the 5-y ... | 2008 | 18435450 |
| prevention of varicella: recommendations of the advisory committee on immunization practices (acip). | two live, attenuated varicella zoster virus-containing vaccines are available in the united states for prevention of varicella: 1) a single-antigen varicella vaccine (varivax, merck & co., inc., whitehouse station, new jersey), which was licensed in the united states in 1995 for use among healthy children aged > or = 12 months, adolescents, and adults; and 2) a combination measles, mumps, rubella, and varicella vaccine (proquad, merck & co., inc., whitehouse station, new jersey), which was licen ... | 2007 | 17585291 |
| incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (std) clinics and the effect of hiv/std risk-reduction counseling. | the seroincidence of herpes simplex virus type 2 (hsv-2) infection was determined among 1766 patients attending sexually transmitted disease (std) clinics and enrolled in a randomized, controlled trial of human immunodeficiency virus (hiv)/std risk-reduction counseling (rrc). arm 1 received enhanced rrc (4 sessions); arm 2, brief rrc (2 sessions); and arm 3, the control arm, brief informational messages. the overall incidence rate was 11.7 cases/100 person-years (py). independent predictors of i ... | 2004 | 15319854 |
| trends in injection drug use among persons entering addiction treatment--new jersey, 1992-1999. | injection drug use is associated with high risk for transmission of bloodborne infections, including human immunodeficiency virus (hiv) and hepatitis b and c. since 1993, the proportion of persons admitted to new jersey addiction treatment centers for illicit drug use who reported injecting drugs has increased, reversing a decline that began in approximately 1980 (1; community epidemiologywork group, unpublished data, 2000). this report summarizes an analysis of trends in injection drug use amon ... | 2001 | 11465905 |
| incidence and consistency of antiretroviral use among hiv-infected medicaid beneficiaries with schizophrenia. | to investigate the incidence and consistency of antiretroviral (arv) treatment in the period before the introduction of protease inhibitors among medicaid beneficiaries in new jersey who had both the human immunodeficiency virus (hiv) and schizophrenia. | 2001 | 11305703 |
| adoption of protective behaviors among persons with recent hiv infection and diagnosis--alabama, new jersey, and tennessee, 1997-1998. | a comprehensive human immunodeficiency virus (hiv) prevention strategy includes knowledge of hiv status, counseling to reduce high-risk behavior, and referral for appropriate care (1). after diagnosis, a substantial percentage of hiv-infected persons reduce their high-risk sexual behaviors (2-4). this report presents data characterizing the sexual practices of persons with newly diagnosed hiv infection who have evidence of recently acquired infection. characterizing these persons may assist in t ... | 2000 | 10882290 |
| success in implementing public health service guidelines to reduce perinatal transmission of hiv--louisiana, michigan, new jersey, and south carolina, 1993, 1995, and 1996. | in 1994, the public health service (phs) published guidelines for zidovudine (zdv) use to reduce perinatal transmission of human immunodeficiency virus (hiv) (1), and in 1995 published guidelines for hiv counseling and voluntary testing of pregnant women (2). to directly assess the implementation of these guidelines and to identify barriers to the continued reduction of perinatal transmission, four states that conduct surveillance for hiv/acquired immunodeficiency syndrome (aids) (louisiana, mic ... | 1998 | 9733415 |
| a descriptive survey of pediatric human immunodeficiency virus-infected long-term survivors. | to identify the population of human immunodeficiency virus-infected pediatric long- term survivors (lts) followed in major medical institutions in california, florida and new jersey. | 1997 | 9099779 |
| responses of health care professionals to proposed mandatory hiv testing. | to survey active health professionals to assess the response to and impact of a mandatory human immunodeficiency virus (hiv) testing policy on health care providers and the communities in which they practice. | 1993 | 8252134 |
| health education and knowledge assessment of htlv-iii diseases among intravenous drug users. | the human t-cell lymphotropic virus, type iii (htlv-iii) is the causative agent of acquired immunodeficiency syndrome (aids). since aids is not curable, public health efforts must be focused on decreasing aids transmission. 72% of all aids cases are male homosexuals; 17% are intravenous (iv) drug users; and 3% are hemophiliacs, blood recipients, and infants of these groups. the gay community is sufficiently organized to provide the necessary infrastructure for aids education and treatment; th ... | 1986 | 3781861 |
| human immunodeficiency virus infections among civilian applicants for united states military service, october 1985 to march 1986. demographic factors associated with seropositivity. | during the six months from october 1985 through march 1986, blood samples from 306,061 civilian applicants for military service from the united states were tested for antibody to the human immunodeficiency virus (hiv). four hundred sixty subjects were positive for the antibody as determined by western (immune) blot reactivity. the mean prevalence of hiv infection in this population of teenagers and young adults was thus 1.50 per 1000. according to multivariate analysis, the following demographic ... | 1987 | 3474519 |
| use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed hiv-infected population. | we used population-based surveillance in new jersey in 1986 to quantify the risk of invasive pneumococcal disease in persons with the acquired immunodeficiency syndrome (aids) and in those who went on to develop aids. using pneumococcal surveillance, we also devised a method to estimate the size of the immunosuppressed population infected with the human immunodeficiency virus (hiv), the so-called pre-aids population. from rates of pneumococcal disease that occurred in areas with a low incidence ... | 1991 | 2046109 |